Literature DB >> 2437869

Pelvic recurrence of rectal cancer. Options for curative resection.

H J Wanebo, D L Gaker, R Whitehill, R F Morgan, W C Constable.   

Abstract

Pelvic recurrence is an ominous event after curative resection of rectal cancer and is rarely amenable to re-resection by conventional methods. A method to permit a composite resection of these using the abdominal sacral approach has been described previously. This report updates that experience with resection of pelvic recurrence of rectal cancer in 28 patients. Of these, 24 were done with curative intent, and four were done for palliation (mainly for infected or fungating tumor). All patients had extensive preoperative evaluation by clinical and radiologic tests, and most patients had a long free interval period of approximately 18 months, after their primary resection. Although 47 patients had exploratory surgery, only 29 had local disease amenable to resection and four had palliative resections. About half the patients had had an abdominoperineal resection, half had had an anterior resection, and one third had had previous efforts to resect the recurrence. All but one patient had been irradiated with 3000-11,000 cGy. All but two patients (of the 24 curative efforts) required a formal abdominosacral resection (through S1-2 in 12, S2-3 in 9, and S4-5 in 1). Over half the patients also required a bladder resection. There were three operative deaths (12%); one patient had a cardiac death immediately after operation and two were septic deaths at 35 and 60 days. The survivors generally had relief of sacral root pain and good motor function; most of those previously employed could return to work. The actuarial 5-year survival rate is 25% and median survival is 36 months. Long-term survival over 48 months was recorded in five of 21 surgical survivors (23.8%). Survival in a historic comparative group of 30 patients treated for local recurrence only (mainly by radiation) was 15 months median, and at 5 years the survival rate was 3% (p less than 0.001). In conclusion, selected patients with pelvic recurrence of rectal cancer may be retrieved by and returned to functional life with the composite abdominosacral resection.

Entities:  

Mesh:

Year:  1987        PMID: 2437869      PMCID: PMC1493032          DOI: 10.1097/00000658-198705000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

2.  An interim report upon the second look procedure for cancer of the stomach, colon, and rectum and for limited intraperitoneal carcinosis.

Authors:  O H WANGENSTEEN; F J LEWIS; S W ARHELGER; J J MULLER; L D MACLEAN
Journal:  Surg Gynecol Obstet       Date:  1954-09

3.  Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy.

Authors:  L L Gunderson; H Sosin
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

4.  Recurrent cancer and metastases.

Authors:  R C Hickey; M M Romsdahl; D E Johnson; S Wallace; G M Mavligit; M E Leavens; B Borgelt
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

5.  Colonoscopy: an essential monitoring technique after resection of colorectal cancer.

Authors:  S W Unger; H J Wanebo
Journal:  Am J Surg       Date:  1983-01       Impact factor: 2.565

6.  Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: implications in treatment planning with adjuvant radiation therapy.

Authors:  W M Mendenhall; R R Million; W W Pfaff
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-07       Impact factor: 7.038

7.  Postoperative screening of patients with carcinoma of the colon.

Authors:  R W Beart; P P Metzger; M J O'Connell; A J Schutt
Journal:  Dis Colon Rectum       Date:  1981 Nov-Dec       Impact factor: 4.585

8.  Pathological studies in rectal cancer.

Authors:  A M Cohen; W C Wood; L L Gunderson; M Shinnar
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

9.  Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum.

Authors:  R M Olson; N P Perencevich; A W Malcolm; J T Chaffey; R E Wilson
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

10.  CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma.

Authors:  E W Martin; J P Minton; L C Carey
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969

View more
  23 in total

1.  Reresection for local recurrence of rectal cancer.

Authors:  W Adachi; A Nishio; H Watanabe; J Igarashi; K Yazawa; Y Nimura; N Koide; A Matsushita; T Monma; K Hanazaki; S Kajikawa; J Amano
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Factors associated with the location of local rectal cancer recurrence and predictors of survival.

Authors:  Peng Du; John P Burke; Wisam Khoury; Ian C Lavery; Ravi P Kiran; Feza H Remzi; David W Dietz
Journal:  Int J Colorectal Dis       Date:  2016-02-10       Impact factor: 2.571

Review 3.  Locally recurrent rectal cancer: surgical strategy.

Authors:  J P de Azevedo; R R Dozois; L L Gunderson
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

Review 4.  The impact of new technology on surgery for colorectal cancer.

Authors:  G B Makin; D J Breen; J R Monson
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

5.  Patterns of recurrence following pelvic exenteration and external radiotherapy for locally advanced primary rectal adenocarcinoma.

Authors:  P Luna-Perez; S Delgado; S Labastida; N Ortiz; D Rodriguez; L Herrera
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

6.  Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.

Authors:  Stephanie Terezakis; Lisa Morikawa; Abraham Wu; Zhigang Zhang; Weiji Shi; Martin R Weiser; Philip B Paty; Jose Guillem; Larissa Temple; Garrett M Nash; Michael J Zelefsky; Karyn A Goodman
Journal:  Ann Surg Oncol       Date:  2015-01-29       Impact factor: 5.344

7.  Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer.

Authors:  Jian-Bin Hu; Xiao-Nan Sun; Qi-Chu Yang; Jing Xu; Qi Wang; Chao He
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

Review 8.  Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives.

Authors:  Markus Rentsch; Tobias Schiergens; Andrej Khandoga; Jens Werner
Journal:  Visc Med       Date:  2016-06-13

9.  Management of locally advanced primary and recurrent rectal cancer.

Authors:  Johannes H W de Wilt; Maarten Vermaas; Floris T J Ferenschild; Cornelis Verhoef
Journal:  Clin Colon Rectal Surg       Date:  2007-08

10.  Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection.

Authors:  Jea-Kun Park; Young-Wan Kim; Hyuk Hur; Nam-Kyu Kim; Byung-Soh Min; Seung-Kook Sohn; Young-Deuk Choi; Young-Tae Kim; Jung-Bai Ahn; Jae-Kyung Roh; Ki-Chang Keum; Jin-Sil Seong
Journal:  Langenbecks Arch Surg       Date:  2008-07-29       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.